Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease

Details for Australian Patent Application No. 2005244483 (hide)

International Classifications

Event Publications

2 November 2006 PCT application entered the National Phase

PCT publication WO2005/110393 Priority application(s): WO2005/110393

9 June 2011 Application Accepted

Published as AU-B-2005244483

6 October 2011 Standard Patent Sealed

26 July 2012 Application for Amendment

The nature of the amendment is: Amend the patentee name from Solvay Pharmaceuticals GmbH to Abbott Products GmbH . Address for service in Australia - Watermark Patent and Trade Marks Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.